Quantitative analysis of cholesterol and cholesteryl esters in human atherosclerotic plaques using near-infrared Raman spectroscopy

被引:43
作者
Weinmann, P
Jouan, M
Dao, NQ
Lacroix, B
Groiselle, C
Bonte, JP
Luc, G
机构
[1] Hop Avicenne, Dept Biophys & Nucl Med, F-93009 Bobigny, France
[2] Ecole Cent Paris, Chatenay Malabry, France
[3] Ctr Univ Mesures & Analyses, Lille, France
[4] Inst Pasteur, Lille, France
关键词
Raman spectroscopy; lipids; atherosclerosis; cholesterol; plaque;
D O I
10.1016/S0021-9150(98)00119-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Raman spectroscopy is a non-destructive analytical technique and previous results have shown that qualitative analysis of the lipid component of human atheromatous arteries is feasible. In this paper, we describe a quantitative analytical method for cholesterol and cholesteryl esters in human atherosclerotic plaques, combined with Raman spectroscopic results, using partial least-squares (PLS) regression, a statistical multivariate method based on factorial analysis. Twenty-nine human atherosclerotic pooled samples were studied and the results of Raman spectroscopy coupled with the PLS method were compared to biochemical results. The standard error of prediction was 16.1, 13.6, 1.9, 3.3 and 3.3 mg/g for total cholesterol, free cholesterol, palmitate cholesteryl, oleate cholesteryl and linoleate cholesteryl, respectively. The repeatability of Raman spectroscopy was found to be excellent. Our results show that Raman spectroscopy is a promising technique to obtain a consistent and non-destructive quantitative analysis of cholesterol and cholesteryl esters in human atherosclerotic lesions. In situ and in vivo analysis is a possibility in the near future. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 42 条
[21]   CHEMICAL-COMPOSITION AND PHYSICAL STATE OF LIPID DEPOSITS IN ATHEROSCLEROSIS [J].
LUNDBERG, B .
ATHEROSCLEROSIS, 1985, 56 (01) :93-110
[22]  
NGUYEN QD, 1986, ANALYSIS, V14, P119
[23]  
PEDERSEN TR, 1994, LANCET, V344, P1383
[24]  
PHAT D, 1991, SPIE, V1525, P196
[25]  
PHAT D, 1991, CIRCULATION, V84, P288
[26]  
QUANG HN, 1992, ANALUSIS, V20, P141
[27]  
QUANG HN, 1993, APPL SPECTROSC, V47, P2013
[28]  
RAPP JH, 1983, J LIPID RES, V24, P1329
[29]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[30]   PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].
SHEPHERD, J ;
COBBE, SM ;
FORD, I ;
ISLES, CG ;
LORIMER, AR ;
MACFARLANE, PW ;
MCKILLOP, JH ;
PACKARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307